News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Elekta: U.S. Patients and Clinics to Benefit from New Revolutionary Beam-Shaping Device



6/14/2012 11:30:37 AM

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Elekta (STO:EKTAB) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Agility™*, a revolutionary beam-shaping device integrated into the head of a linear accelerator (linac). Patients and clinics in the US will now be able to benefit from the speed and reliability of this new MLC design. Elekta has collaborated closely with leading hospitals and research institutions to develop a solution that can increase the throughput of patients while delivering outstanding precision.

Read at BioSpace.com


comments powered by Disqus
Elekta AB
Elekta
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES